Hypertension

Comparative Efficacy of Treatments for Resistant or Uncontrolled Hypertension: A Network Meta-Analysis of Randomized Trials

JACC AdvPublished systematic review and network meta-analysis of randomized trials

Authors' conclusion

In head-to-head comparisons, no significant differences were observed between add-on treatments in reducing blood pressure among patients with resistant or uncontrolled hypertension. Treatment selection should prioritize treatments with demonstrated superiority over baseline treatment, including spironolactone, baxdrostat, and radiofrequency renal denervation.

Study context

Population
Patients with resistant or uncontrolled hypertension35 trials in the systematic review, 30 trials (8,187 patients) in the network meta-analysis · systematic review (35 trials) 8,648 · network meta-analysis (30 trials) 8,187
Participants
8,648 patients
Comparison
Add-on treatments for resistant or uncontrolled hypertension compared with baseline treatment and head-to-head
Outcome
Change in office systolic blood pressure from baseline (patients with resistant hypertension)
Methodological detailsrandom-effects network meta-analysis within a Bayesian framework, certainty of evidence assessed using Confidence In Network Meta-Analysis (CINeMA)
  • Random-effects network meta-analysis within a Bayesian framework
  • Certainty of evidence assessed using CINeMA

Pooled result

As reported in the abstract

CINeMA moderate
Mean difference, mm Hg (95% CrI)
Spironolactonevs baseline treatment
−12.43(−17.68 to −7.18)
Radiofrequency renal denervationvs baseline treatment
−8.74(−12.96 to −4.52)

Further pooled results

Change in office systolic blood pressure in patients with uncontrolled hypertension

Similar findings were observed in patients with uncontrolled hypertension

Head-to-head comparisons between interventions

No intervention demonstrated clear superiority over another because most head-to-head comparisons included the possibility of no effect

Original publication

Comparative Efficacy of Treatments for Resistant or Uncontrolled Hypertension: A Network Meta-Analysis of Randomized Trials. JACC Adv. Published 5 October 2026. doi:10.1016/j.jacadv.2026.103306

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.